|
Click
here for an
audio version (a podcast) of this article.
(Right click and cho0se "Save Target As . . ." to save
the MP3 file to your computer.)
Twenty five years or so ago, as a family physician in a
Christian mission practice in London, I used to help out at a monthly
afternoon clinic with the now dated and politically incorrect name:
“Handicapped Fellowship.” Patients with various physical and mental
disabilities would be transported in by church members to receive health
care, and would then enjoy a British afternoon tea, some entertainment, and
a spiritual message.
It was there that I met two sisters. Both were in their sixties and one had
given up her chances of marriage and independence to look after her younger
sister, Elsie (name changed). We would now describe her as having “learning
difficulties” or “congenital cognitive impairment” or some such, but in
those far off days she would probably at best have been described, by
somebody who wanted to put it kindly, as “a bit simple.”
Yet, one afternoon, another member of the Handicapped Fellowship was trying
to describe Elsie to me. After struggling to find the right words, she
suddenly came out with: “You know, the one who smiles a lot.” It was a
seminal moment. There and then, I learned so much. Perhaps Elsie smiled a
lot because she didn’t really understand the question or comment, and wanted
to disarm criticism. Perhaps she smiled a lot purely by conditioned reflex.
But she smiled a lot, and it made Handicapped Fellowship easier for a
harassed young physician. She smiled a lot and it briefly made the world a
sunnier place. She smiled a lot and in so doing gave us all so much. The
woman describing her thus to me had chosen to emphasize the best thing in a
very lovely woman. In so doing she taught me a valuable lesson about
disability and dignity.
I thought of Elsie again a few weeks ago when I was in Edinburgh, Scotland,
at an excellent conference arranged by the Scottish Council for Human
Bioethics (1). The conference was titled “To Be or Not to Be?” and explored
the ethical implications of embryo selection. One session was a critique of
a then current UK public consultation by Britain’s Human Fertilisation &
Embryology Authority (HFEA). Entitled “Choices and Boundaries” (2) the
consultation was seeking public views about proposals to extend licensing in
the UK of pre-implantation genetic diagnosis (PGD) to avoid passing on a
predisposition to a specific cancer.
PGD has been licensed in the UK for some years. The technique employs
genetic testing on embryos created in the laboratory so that only embryos
free from a gene that would cause a serious disease or disability would be
made available for implantation into the commissioning woman. Thus any baby
born would be free from that particular genetic disease. (It is rarely
spelled out – and was not spelled out in the HFEA consultation document -
that many human embryos who are found to be affected have therefore
inevitably to be discarded to die.)
To date, around 50 genetic conditions have been tested for in embryos under
licenses issued by the HFEA. Even so, only around 1000 babies have
consequently been born. Testing is very expensive financially for would-be
parents, and in terms of discarded embryos is of course very wasteful of
early human life.
The HFEA consultation (which closed January 16 with a report expected in
spring 2006) was to explore public attitudes to extending the legality of
PGD testing to lower penetrance susceptibility conditions. Here, possessing
the gene in question results in a predisposition to an inherited cancer, but
not a guarantee that anyone possessing that gene will get that cancer.
Examples include inherited forms of ovarian and breast cancer susceptibility
and a particular type of inherited bowel cancer susceptibility.
So, it is proposed that there be intervention, fatal for many, regarding
conditions which even if they developed, could be detected in adult life by
screening, could be detected early because individuals and their physicians
would be aware of the increased possibility, and could then be treated by
the early application of current therapies or those likely to be developed
as the years unfold. There is thus a big bioethical decision for the HFEA to
make soon on behalf of the British public. And given the respect shown,
rightly or wrongly, around the world to Britain’s HFEA as a model, their
decision is likely to have considerable impact globally.
But if that’s the bioethics, what might all this mean for
global understandings of human dignity? That’s what brought to mind Elsie,
“the one who smiles a lot”. In that part of the HFEA consultation document
which addressed factors “to be considered when deciding the appropriateness
of PGD” the bullet points included, chillingly, “the extent of any
intellectual impairment.” Elsie, you wouldn’t have made it.
This is surely eugenics at its most blatant, and a British government body
is brazenly proposing this in public. For a condition that possibly might
develop, which if it did could be detected early, which if it did could be
treated by current therapies or those to come, whose management we might
have expected to depend on the fully informed views of the young or older
adult considering their future, it is proposed we make sure they never have
a chance of being born. And should that condition, horror of horrors,
include a degree of intellectual impairment, that would be an even greater
reason for the fatal intervention.
Elsie, you smiled a lot. You had dignity. So did your sister. So did the one
who found those lovely words to describe you. Is such dignity to disappear
for ever in a brave new eugenic world of PGD? CBHD
References
- A conference report may be
available from the
Scottish Council on Human Bioethics,
15 Morningside Road, Edinburgh EH10 4DP, Scotland. Tel. 01144 131 447
6394.
- Choices and Boundaries. Should people be able
to select embr
yos free from
an inherited susceptibility to cancer?
Human Fertilisation and Embryology Authority, 21 Bloomsbury Street,
London WC1B 3HF, England. Tel. 01144 207 291 8200.
Andrew Fergusson, MB BS. Andrew is currently Strategy Advisor on Euthanasia for Christian Medial Fellowship.
Copyright 2006 by The Center for Bioethics and Human
Dignity
The contents of this article do not necessarily reflect the opinions of
CBHD, its staff, board or supporters. Permission to reprint granted as long as The Center for Bioethics and
Human Dignity and the web address for this article is referenced.
|